Skip to content
Disclosery

VANGUARD GROUP INC: RNA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of VANGUARD GROUP INC on RNA, newest first. How the timeline and the estimate are built.

VANGUARD GROUP INC held 947,572 RNA shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 947,572 shares
    Change vs previous 13F -124,379 shares

    <0.01% of the 13F portfolio, value $12,744,843.

    13F-HR 0002100119-26-001527 filed by VANGUARD CAPITAL MANAGEMENT LLC
    Filed (acceptance time not in the bulk data set), ingested

    • VANGUARD FIDUCIARY TRUST CO: 109,961 shares
    • Vanguard Global Advisers, LLC: 5,585 shares
    • VANGUARD CAPITAL MANAGEMENT LLC: 730,831 shares
    • VANGUARD PORTFOLIO MANAGEMENT LLC: 101,195 shares

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 1,071,951 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $14,331,985.

    13F-HR/A 0002100119-26-001311 filed by VANGUARD CAPITAL MANAGEMENT LLC
    Filed (acceptance time not in the bulk data set), ingested

    • VANGUARD FIDUCIARY TRUST CO: 95,128 shares
    • Vanguard Global Advisers, LLC: 5,585 shares
    • VANGUARD CAPITAL MANAGEMENT LLC: 626,869 shares
    • VANGUARD PORTFOLIO MANAGEMENT LLC: 344,369 shares

    Acceptance time not in the bulk data set (spec §4.2).